Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Nussbaumer, S., Bonnabry, P., Veuthey, J. L. & Fleury-Souverain, S. Analysis of anticancer drugs: a review. Talanta 85, 2265–2289 (2011).
2. Chari, R. V. J. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Accounts Chem Res 41, 98–107 (2008).
3. Tacar, O., Sriamornsak, P. & Dass, C. R. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65, 157–170 (2013).
4. Magdy, T., Burmeister, B. T. & Burridge, P. W. Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing? Pharmacol Ther 168, 113–125 (2016).
5. Yang, Q. J. et al. Protective effects of dexrazoxane against doxorubicin-induced cardiotoxicity: a metabolomic study. PLoS One 12, 1–18 (2017).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献